Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 9, Issue 6, Pages 737-743Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2009.06.016
Keywords
-
Categories
Funding
- FRS-FNRS (Fonds de la Recherche Scientifique, Belgique)
- FRSM (Fonds de la Resecherche Scientifique et medicale) FRS-FNRS
- 'fonds speciaux de recherche', UCL (Universite catholique de Louvain)
Ask authors/readers for more resources
Obesity and associated metabolic disorders are worldwide epidemic. The literature provides new evidence that gut microbiota dysbiosis (at the phyla, genus, or species level) affects host metabolism and energy storage. Here we discuss new findings that may explain how gut microbiota can be involved in the development or in the control of obesity and associated low-grade inflammation. New powerful molecular biology methods and the use of gnotobiotic animal allowed to analyze the molecular link between gut bacteria and the host. Moreover, even if more studies are needed to unravel how changing gut microbiota impacts on the development of obesity and related metabolic alterations, probiotic and prebiotic approach appear as potential interesting treatments to reverse host metabolic alterations linked to gut microbiota dysbiosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available